{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T19:14:23Z","timestamp":1792005263911,"version":"4.4.0"},"reference-count":76,"publisher":"European Respiratory Society (ERS)","issue":"6","license":[{"start":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T00:00:00Z","timestamp":1588550400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.ersjournals.com\/user-licence"}],"content-domain":{"domain":["publications.ersnet.org"],"crossmark-restriction":true},"short-container-title":["Eur Respir J"],"accepted":{"date-parts":[[2020,3,2]]},"published-print":{"date-parts":[[2020,6]]},"abstract":"<jats:p>Inhaled corticosteroids (ICS) combined with bronchodilators can reduce the frequency of exacerbations in some patients with chronic obstructive pulmonary disease (COPD). There is evidence, however, that ICS are frequently used in patients where their benefit has not been established. Therefore, there is a need for a personalised approach to the use of ICS in COPD and to consider withdrawal of ICS in patients without a clear indication. This document reports European Respiratory Society recommendations regarding ICS withdrawal in patients with COPD.<\/jats:p>\n                  <jats:p>Comprehensive evidence synthesis was performed to summarise all available evidence relevant to the question: should ICS be withdrawn in patients with COPD? The evidence was appraised using the GRADE (Grading of Recommendations, Assessment, Development and Evaluation) approach and the results were summarised in evidence profiles. The evidence synthesis was discussed and recommendations formulated by a committee with expertise in COPD and guideline methodology.<\/jats:p>\n                  <jats:p>\n                    After considering the balance of desirable and undesirable consequences, quality of evidence, and feasibility and acceptability of interventions, the guideline panel made: 1) conditional recommendation for the withdrawal of ICS in patients with COPD without a history of frequent exacerbations, 2) strong recommendation not to withdraw ICS in patients with blood eosinophil counts \u2265300\u2005eosinophils\u00b7\u00b5L\n                    <jats:sup>\u22121<\/jats:sup>\n                    and 3) strong recommendation to treat with one or two long-acting bronchodilators if ICS are withdrawn.\n                  <\/jats:p>\n                  <jats:p>A conditional recommendation indicates that there was uncertainty about the balance of desirable and undesirable consequences of the intervention, and that well-informed patients may make different choices regarding whether to have or not have the specific intervention.<\/jats:p>","DOI":"10.1183\/13993003.00351-2020","type":"journal-article","created":{"date-parts":[[2020,5,4]],"date-time":"2020-05-04T20:35:39Z","timestamp":1588624539000},"page":"2000351","update-policy":"https:\/\/doi.org\/10.1183\/ers-crossmark-policy","source":"Crossref","is-referenced-by-count":109,"title":["Withdrawal of inhaled corticosteroids in COPD: a European Respiratory Society guideline"],"prefix":"10.1183","volume":"55","author":[{"given":"James D.","family":"Chalmers","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8778-2823","authenticated-orcid":false,"given":"Irena F.","family":"Laska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1633-6356","authenticated-orcid":false,"given":"Frits M.E.","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1830-2982","authenticated-orcid":false,"given":"Wim","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pavord","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Rigau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5721-5710","authenticated-orcid":false,"given":"Melissa J.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Roche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Don D.","family":"Sin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daiana","family":"Stolz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samy","family":"Suissa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jadwiga","family":"Wedzicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9850-9520","authenticated-orcid":false,"given":"Marc","family":"Miravitlles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"81","published-online":{"date-parts":[[2020,5,4]]},"reference":[{"key":"2026061109501126000_55.6.2000351.1","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00164-2019"},{"key":"2026061109501126000_55.6.2000351.2","doi-asserted-by":"publisher","DOI":"10.1517\/14656566.2015.1067682"},{"key":"2026061109501126000_55.6.2000351.3","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1038\/s41533-017-0040-z","article-title":"Determinants of initial inhaled corticosteroid use in patients with GOLD A\/B COPD: a retrospective study of UK general practice","volume":"27","author":"Chalmers","year":"2017","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026061109501126000_55.6.2000351.4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12931-018-0767-2","article-title":"Assessing the healthcare resource use associated with inappropriate prescribing of inhaled corticosteroids for people with chronic obstructive pulmonary disease (COPD) in GOLD groups A or B: an observational study using the Clinical Practice Research Data","volume":"19","author":"Chalmers","year":"2018","journal-title":"Respir Res"},{"key":"2026061109501126000_55.6.2000351.5","doi-asserted-by":"publisher","DOI":"10.2147\/copd.S164259"},{"key":"2026061109501126000_55.6.2000351.6","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00128914"},{"key":"2026061109501126000_55.6.2000351.7","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00451-2017"},{"key":"2026061109501126000_55.6.2000351.8","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2012-201772"},{"key":"2026061109501126000_55.6.2000351.9","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.167.19.2047"},{"key":"2026061109501126000_55.6.2000351.10","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-2600(16)30148-5","article-title":"Blood eosinophil count and pneumonia risk in patients with chronic obstructive pulmonary disease: a patient-level meta-analysis","volume":"4","author":"Pavord","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2026061109501126000_55.6.2000351.11","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1038\/s41533-019-0150-x","article-title":"Inhaled corticosteroids in COPD and onset of type 2 diabetes and osteoporosis: matched cohort study","volume":"29","author":"Price","year":"2019","journal-title":"NPJ Prim Care Respir Med"},{"key":"2026061109501126000_55.6.2000351.12","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S2213-2600(13)70040-7","article-title":"Once-daily inhaled fluticasone furoate and vilanterol versus vilanterol only for prevention of exacerbations of COPD: two replicate double-blind, parallel-group, randomised controlled trials","volume":"1","author":"Dransfield","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026061109501126000_55.6.2000351.13","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2018.04.013"},{"key":"2026061109501126000_55.6.2000351.14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-2600(18)30006-7","article-title":"Predictors of exacerbation risk and response to budesonide in patients with chronic obstructive pulmonary disease: a post-hoc analysis of three randomised trials","volume":"6","author":"Bafadhel","year":"2018","journal-title":"Lancet Respir Med"},{"key":"2026061109501126000_55.6.2000351.15","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00162414"},{"key":"2026061109501126000_55.6.2000351.16","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.02177-2017"},{"key":"2026061109501126000_55.6.2000351.17","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00427-2018"},{"key":"2026061109501126000_55.6.2000351.18","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2018.03.016"},{"key":"2026061109501126000_55.6.2000351.19","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200206-512OC"},{"key":"2026061109501126000_55.6.2000351.20","doi-asserted-by":"publisher","DOI":"10.1016\/j.pcrj.2003.11.005"},{"key":"2026061109501126000_55.6.2000351.21","doi-asserted-by":"publisher","DOI":"10.1136\/thx.2004.034280"},{"key":"2026061109501126000_55.6.2000351.22","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-8-93"},{"key":"2026061109501126000_55.6.2000351.23","doi-asserted-by":"publisher","DOI":"10.1016\/j.rmed.2011.07.002"},{"key":"2026061109501126000_55.6.2000351.24","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1164\/ajrccm.164.3.2002052","article-title":"Effects of withdrawal of inhaled steroids in men with severe irreversible airflow obstruction","volume":"164","author":"O'Brien","year":"2001","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061109501126000_55.6.2000351.25","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1407154"},{"key":"2026061109501126000_55.6.2000351.26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1164\/rccm.201803-0405OC","article-title":"Long-term triple therapy de-escalation to indacaterol\/glycopyrronium in patients with chronic obstructive pulmonary disease (SUNSET): a randomized, double-blind, triple-dummy clinical trial","volume":"198","author":"Chapman","year":"2018","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061109501126000_55.6.2000351.27","doi-asserted-by":"publisher","DOI":"10.1186\/1465-9921-12-107"},{"key":"2026061109501126000_55.6.2000351.28","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.pupt.2017.06.002","article-title":"Withdrawal of inhaled corticosteroids in COPD: a meta-analysis","volume":"45","author":"Calzetta","year":"2017","journal-title":"Pulm Pharmacol Ther"},{"key":"2026061109501126000_55.6.2000351.29","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12931-017-0682-y","article-title":"A proposal for the withdrawal of inhaled corticosteroids in the clinical practice of chronic obstructive pulmonary disease","volume":"18","author":"Miravitlles","year":"2017","journal-title":"Respir Res"},{"key":"2026061109501126000_55.6.2000351.30","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2147\/COPD.S207775","article-title":"Withdrawal of inhaled corticosteroids in COPD patients: rationale and algorithms","volume":"14","author":"Avdeev","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026061109501126000_55.6.2000351.31","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.2147\/COPD.S216059","article-title":"A framework for step down or therapeutic re-organization for withdrawal of inhaled corticosteroids in selected patients with COPD: a proposal for COPD management","volume":"14","author":"Micheletto","year":"2019","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026061109501126000_55.6.2000351.32","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/15412555.2017.1342233","article-title":"Should patients switched from D to B in the GOLD 2017 classification be discontinued from inhaled corticosteroids?","volume":"14","author":"Harlander","year":"2017","journal-title":"COPD"},{"key":"2026061109501126000_55.6.2000351.33","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2147\/COPD.S93321","article-title":"Applying the wisdom of stepping down inhaled corticosteroids in patients with COPD: a proposed algorithm for clinical practice","volume":"10","author":"Kaplan","year":"2015","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026061109501126000_55.6.2000351.34","first-page":"214","article-title":"COPD: a stepwise or a hit hard approach?","volume":"22","author":"Ferreira","year":"2016","journal-title":"Rev Port Pneumol"},{"key":"2026061109501126000_55.6.2000351.35","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0161248"},{"key":"2026061109501126000_55.6.2000351.36","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00221-2018"},{"key":"2026061109501126000_55.6.2000351.37","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2010.09.012"},{"key":"2026061109501126000_55.6.2000351.38","doi-asserted-by":"publisher","DOI":"10.1136\/bmj.b2535"},{"key":"2026061109501126000_55.6.2000351.39","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200602-197ST"},{"key":"2026061109501126000_55.6.2000351.40","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201310-1863PP"},{"key":"2026061109501126000_55.6.2000351.41","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2012.03.013"},{"key":"2026061109501126000_55.6.2000351.42","doi-asserted-by":"publisher","DOI":"10.1016\/j.jclinepi.2016.07.006"},{"key":"2026061109501126000_55.6.2000351.43","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00126814"},{"key":"2026061109501126000_55.6.2000351.44","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/S2213-2600(16)00100-4","article-title":"Blood eosinophil count and exacerbations in severe chronic obstructive pulmonary disease after withdrawal of inhaled corticosteroids: a post-hoc analysis of the WISDOM trial","volume":"4","author":"Watz","year":"2016","journal-title":"Lancet Respir Med"},{"key":"2026061109501126000_55.6.2000351.45","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1111\/resp.13374","article-title":"Efficacy and safety of the direct switch to indacaterol\/glycopyrronium from salmeterol\/fluticasone in non-frequently exacerbating COPD patients: the FLASH randomized controlled trial","volume":"23","author":"Frith","year":"2018","journal-title":"Respirology"},{"key":"2026061109501126000_55.6.2000351.46","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1164\/rccm.201609-1794CI","article-title":"How do dual long-acting bronchodilators prevent exacerbations of chronic obstructive pulmonary disease?","volume":"196","author":"Beeh","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061109501126000_55.6.2000351.47","doi-asserted-by":"crossref","first-page":"193","DOI":"10.2147\/COPD.S95055","article-title":"The lung function profile of once-daily tiotropium and olodaterol via Respimat is superior to that of twice-daily salmeterol and fluticasone propionate via Accuhaler (ENERGITO study)","volume":"11","author":"Beeh","year":"2016","journal-title":"Int J Chron Obstruct Pulmon Dis"},{"key":"2026061109501126000_55.6.2000351.48","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1186\/s12931-017-0683-x","article-title":"Efficacy and safety of tiotropium and olodaterol in COPD: a systematic review and meta-analysis","volume":"18","author":"Miravitlles","year":"2017","journal-title":"Respir Res"},{"key":"2026061109501126000_55.6.2000351.49","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1164\/rccm.201607-1421OC","article-title":"Effect of fluticasone furoate and vilanterol on exacerbations of chronic obstructive pulmonary disease in patients with moderate airflow obstruction","volume":"195","author":"Martinez","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061109501126000_55.6.2000351.50","doi-asserted-by":"publisher","DOI":"10.1136\/thoraxjnl-2017-210408"},{"key":"2026061109501126000_55.6.2000351.51","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2017.04.022"},{"key":"2026061109501126000_55.6.2000351.52","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00222-2018"},{"key":"2026061109501126000_55.6.2000351.53","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01940-2018"},{"key":"2026061109501126000_55.6.2000351.54","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01202-2018"},{"key":"2026061109501126000_55.6.2000351.55","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00214-2017"},{"key":"2026061109501126000_55.6.2000351.56","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01848-2018"},{"key":"2026061109501126000_55.6.2000351.57","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.rmed.2015.12.004","article-title":"Treatment patterns in COPD patients newly diagnosed in primary care. A population-based study","volume":"111","author":"Barrecheguren","year":"2016","journal-title":"Respir Med"},{"key":"2026061109501126000_55.6.2000351.58","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-2600(12)70052-8","article-title":"Efficacy and safety of once-daily QVA149 compared with twice-daily salmeterol\u2013fluticasone in patients with chronic obstructive pulmonary disease (ILLUMINATE): a randomised, double-blind, parallel group study","volume":"1","author":"Vogelmeier","year":"2013","journal-title":"Lancet Respir Med"},{"key":"2026061109501126000_55.6.2000351.59","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516385"},{"key":"2026061109501126000_55.6.2000351.60","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1164\/rccm.201701-0193OC","article-title":"Blood eosinophils and response to maintenance chronic obstructive pulmonary disease treatment. Data from the FLAME trial","volume":"195","author":"Roche","year":"2017","journal-title":"Am J Respir Crit Care Med"},{"key":"2026061109501126000_55.6.2000351.61","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1713901"},{"key":"2026061109501126000_55.6.2000351.62","doi-asserted-by":"publisher","DOI":"10.2147\/COPD.S179425"},{"key":"2026061109501126000_55.6.2000351.63","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01586-2018"},{"key":"2026061109501126000_55.6.2000351.64","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01370-2015"},{"key":"2026061109501126000_55.6.2000351.65","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(16)30069-1"},{"key":"2026061109501126000_55.6.2000351.66","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa063070"},{"key":"2026061109501126000_55.6.2000351.67","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01230-2018"},{"key":"2026061109501126000_55.6.2000351.68","doi-asserted-by":"publisher","DOI":"10.1378\/chest.15-0627"},{"key":"2026061109501126000_55.6.2000351.69","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00436-2016"},{"key":"2026061109501126000_55.6.2000351.70","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00328-2018"},{"key":"2026061109501126000_55.6.2000351.71","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00629-2017"},{"key":"2026061109501126000_55.6.2000351.72","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.00250-2019"},{"key":"2026061109501126000_55.6.2000351.73","doi-asserted-by":"publisher","DOI":"10.1183\/09031936.00077010"},{"key":"2026061109501126000_55.6.2000351.74","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01896-2018"},{"key":"2026061109501126000_55.6.2000351.75","doi-asserted-by":"publisher","DOI":"10.1183\/13993003.01219-2018"},{"key":"2026061109501126000_55.6.2000351.76","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1080\/15412555.2019.1608172","article-title":"Blood eosinophil counts, withdrawal of inhaled corticosteroids and risk of COPD exacerbations and mortality in the Clinical Practice Research Datalink (CPRD)","volume":"16","author":"Oshagbemi","year":"2019","journal-title":"COPD"}],"container-title":["European Respiratory Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1183\/13993003.00351-2020","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:50:24Z","timestamp":1781196624000},"score":1,"resource":{"primary":{"URL":"https:\/\/publications.ersnet.org\/lookup\/doi\/10.1183\/13993003.00351-2020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,5,4]]},"references-count":76,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2020,6,4]]},"published-print":{"date-parts":[[2020,6]]}},"alternative-id":["10.1183\/13993003.00351-2020"],"URL":"https:\/\/doi.org\/10.1183\/13993003.00351-2020","relation":{},"ISSN":["0903-1936","1399-3003"],"issn-type":[{"value":"0903-1936","type":"print"},{"value":"1399-3003","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,5,4]]}}}